Cash flow RemeGen Co., Ltd.

Equities

9995

CNE1000048G6

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 01:38:29 18/05/2026 pm IST			5-day change	1st Jan Change
85.80 ^HKD	-3.97%		-12.18%	+19.17%

15/05	RemeGen Invests in Wealth Management Products	MT
05/05	BlackRock's long position in H-shares of Remegen decreases to 4.59% on April 29 from 5.96%, HKEX filing shows	RE

430813114aed87889d1.Up00JCcVtVgKRz5wnhdQTEe8JUTtFLHir1BBhtZG_Fc.A_YFRW4j3m4zEUob0VIofDPJEhSYUN3TzgcTzYM3mhgAxQNAH1fzInA3cw

Published financial data: REMEGEN CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	142.39Cr	77Cr	107.61Cr	171.02Cr	324.16Cr
Other Revenues, Total	-	-	68.23L	67.1L	94.92L
Total Revenues	142.39Cr	77Cr	108.3Cr	171.69Cr	325.11Cr
Cost of Goods Sold, Total	6.72Cr	27Cr	26Cr	35Cr	42Cr
Gross Profit	135.67Cr	50Cr	83Cr	137.01Cr	283.56Cr
Selling General & Admin Expenses, Total	48Cr	71Cr	107.94Cr	126.55Cr	147.57Cr
Provision for Bad Debts	1L	1.05Cr	79.14L	45.11L	20.73L
R&D Expenses	71Cr	98Cr	130.63Cr	153.98Cr	121.87Cr
Other Operating Expenses	4.12Cr	1.49Cr	-2.26Cr	-1.49Cr	-8L
Other Operating Expenses, Total	123.51Cr	172.08Cr	237.11Cr	279.48Cr	269.57Cr
Operating Income	12Cr	-122.29Cr	-154.54Cr	-142.47Cr	14Cr
Interest Expense, Total	-53.23L	-67.57L	-2.31Cr	-7.24Cr	-7.02Cr
Interest And Investment Income	4.33Cr	6.15Cr	3.51Cr	1.02Cr	45.94L
Net Interest Expenses	3.8Cr	5.48Cr	1.2Cr	-6.21Cr	-6.56Cr
Currency Exchange Gains (Loss)	-2.55Cr	1.32Cr	15.33L	-71.31L	9L
Other Non Operating Income (Expenses)	14Cr	15Cr	-45.78L	-67.87L	13.16L
EBT, Excl. Unusual Items	28Cr	-100.93Cr	-153.64Cr	-150.07Cr	7.65Cr
Gain (Loss) On Sale Of Investments	-2L	1.15Cr	-	-27.55L	64Cr
Gain (Loss) On Sale Of Assets	-3L	-10.03L	-8L	-9L	-9L
Other Unusual Items	1T	-	2.6Cr	3.61Cr	-15L
EBT, Incl. Unusual Items	28Cr	-100Cr	-151.12Cr	-146.84Cr	71Cr
Income Tax Expense	-	-	-	-	7L
Earnings From Continuing Operations	28Cr	-100Cr	-151.12Cr	-146.84Cr	71Cr
Net Income to Company	28Cr	-100Cr	-151.12Cr	-146.84Cr	71Cr
Net Income - (IS)	28Cr	-100Cr	-151.12Cr	-146.84Cr	71Cr
Net Income to Common Incl Extra Items	28Cr	-100Cr	-151.12Cr	-146.84Cr	71Cr
Net Income to Common Excl. Extra Items	28Cr	-100Cr	-151.12Cr	-146.84Cr	71Cr
Per Share Items
Net EPS - Basic	0.57	-1.88	-2.8	-2.73	1.29
Basic EPS - Continuing Operations	0.57	-1.88	-2.8	-2.73	1.29
Basic Weighted Average Shares Outstanding	49Cr	53Cr	54Cr	54Cr	55Cr
Net EPS - Diluted	0.57	-1.88	-2.8	-2.73	1.29
Diluted EPS - Continuing Operations	0.57	-1.88	-2.8	-2.73	1.29
Diluted Weighted Average Shares Outstanding	49Cr	53Cr	54Cr	54Cr	55Cr
Normalized Basic EPS	0.35	-1.19	-1.78	-1.74	0.09
Normalized Diluted EPS	0.35	-1.19	-1.78	-1.74	0.09
Payout Ratio	-	-	-1.02	-4.76	10.15
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	19Cr	-110.15Cr	-137.34Cr	-119.37Cr	39Cr
EBITA	12Cr	-122.24Cr	-154.43Cr	-142.22Cr	14Cr
EBIT	12Cr	-122.29Cr	-154.54Cr	-142.47Cr	14Cr
EBITDAR	19Cr	-109.83Cr	-137.08Cr	-118.55Cr	40Cr
Total Revenues (As Reported)	-	-	108.3Cr	171.69Cr	325.11Cr
Effective Tax Rate - (Ratio)	-	-	-	-	0.11
Normalized Net Income	17Cr	-63Cr	-96Cr	-94Cr	4.78Cr
Interest Capitalized	1L	-	11.93L	47.68L	58.21L
Interest on Long-Term Debt	53.23L	67.57L	89.67L	1.06Cr	89.45L
Supplemental Operating Expense Items
Marketing Expenses	-	-	26Cr	33Cr	45Cr
Selling and Marketing Expenses	26Cr	44Cr	78Cr	95Cr	111.14Cr
General and Administrative Expenses	22Cr	27Cr	30Cr	32Cr	36Cr
Research And Development Expense From Footnotes	71Cr	98Cr	130.63Cr	155.62Cr	121.87Cr
Net Rental Expense, Total	60.82L	31.99L	25.95L	81.57L	67.63L
Imputed Operating Lease Interest Expense	17.56L	12.91L	7L	25.62L	16.88L
Imputed Operating Lease Depreciation	43.26L	19.08L	18.87L	55.95L	50.75L
Stock-Based Comp., COGS (Total)	-	-	12.23L	20.5L	-
Stock-Based Comp., R&D Exp. (Total)	-	-	6.05Cr	4.02Cr	95.67L
Stock-Based Comp., S&M Exp. (Total)	-	-	67.38L	84.22L	59.53L
Stock-Based Comp., G&A Exp. (Total)	-	-	1.71Cr	1.83Cr	1.37Cr
Stock-Based Comp., Other (Total)	1.92Cr	5.58Cr	-	-2L	47.25L
Total Stock-Based Compensation	1.92Cr	5.58Cr	8.56Cr	6.87Cr	3.39Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	175.68Cr	206.92Cr	74Cr	76Cr	119.75Cr
Short Term Investments	61.42L	1.73Cr	-	-	93.69L
Trading Asset Securities, Total	-	-	-	-	121.55Cr
Total Cash And Short Term Investments	176.3Cr	208.65Cr	74Cr	76Cr	242.24Cr
Accounts Receivable, Total	70.5L	28Cr	42Cr	60Cr	72Cr
Other Receivables	2.88Cr	49.15L	5.3Cr	2.75Cr	8.81Cr
Total Receivables	3.58Cr	29Cr	47Cr	63Cr	81Cr
Inventory	28Cr	52Cr	74Cr	66Cr	66Cr
Other Current Assets, Total	22Cr	32Cr	27Cr	24Cr	9.18Cr
Total Current Assets	230Cr	321.21Cr	222.89Cr	228.98Cr	398.19Cr
Gross Property Plant And Equipment	194.07Cr	293.95Cr	365.87Cr	381.45Cr	423.53Cr
Accumulated Depreciation	-21Cr	-33Cr	-70Cr	-98Cr	-126.92Cr
Net Property Plant And Equipment	172.65Cr	261.15Cr	295.93Cr	283.42Cr	296.61Cr
Long-term Investments	1.21Cr	8.12Cr	9.82Cr	7.22Cr	14Cr
Other Intangibles, Total	1.31Cr	1.75Cr	14Cr	14Cr	15Cr
Deferred Charges Long-Term	-	-	68.34L	43.25L	7L
Other Long-Term Assets, Total	11Cr	9.89Cr	9.12Cr	15Cr	79.53L
Total Assets	415.92Cr	602.12Cr	552.82Cr	549.85Cr	724.81Cr
Liabilities
Accounts Payable, Total	17Cr	22Cr	14Cr	16Cr	29Cr
Accrued Expenses, Total	11Cr	19Cr	33Cr	37Cr	48Cr
Short-term Borrowings	-	-	28Cr	108.39Cr	122.18Cr
Current Portion of Long-Term Debt	-	-	20.72L	29Cr	20Cr
Current Portion of Leases	5.25Cr	6.02Cr	5.84Cr	6.23Cr	2.34Cr
Current Income Taxes Payable	61.26L	1.47Cr	20.1L	21.36L	49.6L
Unearned Revenue Current, Total	3.16Cr	1.54Cr	1.14Cr	31.44L	32Cr
Other Current Liabilities	24Cr	39Cr	30Cr	21Cr	24Cr
Total Current Liabilities	62Cr	89Cr	112.81Cr	217.83Cr	278.75Cr
Long-Term Debt	-	-	84Cr	119.59Cr	73Cr
Long-Term Leases	5.03Cr	10Cr	7.47Cr	4.21Cr	1.97Cr
Unearned Revenue Non Current	4.58Cr	4.37Cr	4.61Cr	9.6Cr	8.93Cr
Deferred Tax Liability Non Current	3L	40T	15.11L	-	1.06Cr
Total Liabilities	71Cr	104.09Cr	209.1Cr	351.23Cr	363.93Cr
Common Stock, Total	49Cr	54Cr	54Cr	54Cr	56Cr
Additional Paid In Capital	370.93Cr	616.09Cr	616.09Cr	629.1Cr	692.38Cr
Retained Earnings	-34Cr	-134.23Cr	-285.35Cr	-432.19Cr	-360.67Cr
Treasury Stock	-45Cr	-46Cr	-44Cr	-45Cr	-24Cr
Comprehensive Income and Other	3.99Cr	8.05Cr	2.6Cr	-8.19Cr	-3.48Cr
Total Common Equity	344.64Cr	498.03Cr	343.73Cr	198.62Cr	360.88Cr
Total Equity	344.64Cr	498.03Cr	343.73Cr	198.62Cr	360.88Cr
Total Liabilities And Equity	415.92Cr	602.12Cr	552.82Cr	549.85Cr	724.81Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	48Cr	54Cr	54Cr	54Cr	56Cr
ECS Total Common Shares Outstanding	48Cr	54Cr	54Cr	54Cr	56Cr
Book Value / Share	7.11	9.25	6.39	3.7	6.45
Tangible Book Value	343.33Cr	496.28Cr	329.35Cr	184.31Cr	345.63Cr
Tangible Book Value Per Share	7.08	9.22	6.12	3.43	6.18
Total Debt	10Cr	17Cr	126Cr	267.05Cr	220.17Cr
Net Debt	-166.02Cr	-192.15Cr	52Cr	190.8Cr	-22Cr
Debt Equivalent Oper. Leases	4.87Cr	2.56Cr	2.08Cr	6.53Cr	5.41Cr
Equity Method Investments, Total	-	15L	27.05L	88.51L	1.38Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	18Cr	28Cr	33Cr	22Cr	23Cr
Inventories - Work In Process, Total	9.75Cr	21Cr	37Cr	41Cr	40Cr
Inventories - Finished Goods, Total	71.28L	2.66Cr	4.57Cr	2.8Cr	3.51Cr
Inventories - Others	-	-	10.56L	6L	3L
Buildings, Total	49Cr	74Cr	134.68Cr	149.05Cr	156.71Cr
Machinery, Total	69Cr	97Cr	118.12Cr	168.93Cr	167.95Cr
Full Time Employees	2.12T	3.33T	3.62T	3T	3.05T
Accumulated Allowance for Doubtful Accounts (Supple)	1L	1.06Cr	1.57Cr	2.02Cr	2.23Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	28Cr	-100Cr	-151.12Cr	-146.84Cr	71Cr
Depreciation & Amortization - CF	12Cr	18Cr	23Cr	29Cr	31Cr
Amortization of Goodwill and Intangible Assets - (CF)	8L	5L	11.29L	24.99L	24.99L
Depreciation & Amortization, Total	12Cr	18Cr	23Cr	29Cr	31Cr
Amortization of Deferred Charges, Total - (CF)	15.06L	29.25L	72.87L	1.18Cr	1.09Cr
(Gain) Loss From Sale Of Asset	3L	10.18L	-4.17T	7L	8L
(Gain) Loss on Sale of Investments - (CF)	-	-1.21Cr	-69.75L	-24.04L	-65Cr
Asset Writedown & Restructuring Costs	-	-	8L	-13.12L	15.92L
Stock-Based Compensation (CF)	1.92Cr	5.58Cr	8.56Cr	6.87Cr	3.39Cr
Provision and Write-off of Bad Debts	1L	1.05Cr	79.14L	45.11L	20.73L
Other Operating Activities, Total	1.51Cr	1.68Cr	4.1Cr	8.84Cr	7.48Cr
Change In Accounts Receivable	-3.93Cr	-49Cr	-34Cr	-33Cr	-102.31Cr
Change In Inventories	-21Cr	-24Cr	-23Cr	7.24Cr	-7L
Change In Accounts Payable	2.03Cr	5.81Cr	22Cr	15Cr	58Cr
Change in Unearned Revenues	-1.84Cr	-1.07Cr	-	-	-
Change in Other Net Operating Assets	8.33Cr	16Cr	-	-	-
Cash from Operations	26Cr	-126.37Cr	-150.28Cr	-111.43Cr	5.3Cr
Capital Expenditure	-62Cr	-76Cr	-85Cr	-27Cr	-20Cr
Sale of Property, Plant, and Equipment	-	2L	66.52T	72.01L	21.3L
Sale (Purchase) of Intangible assets	-22.67L	-19.44L	-	-	-
Investment in Marketable and Equity Securities, Total	-	-5.88Cr	-6.53Cr	-41.49L	-1.74Cr
Other Investing Activities, Total	-2.06Cr	-2.54Cr	10Cr	1.4Cr	95.78L
Cash from Investing	-64Cr	-84Cr	-82Cr	-25Cr	-21Cr
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	112.58Cr	180.46Cr	203.47Cr
Total Debt Issued	-	-	112.58Cr	180.46Cr	203.47Cr
Short Term Debt Repaid, Total	-11Cr	-	-	-	-
Long-Term Debt Repaid, Total	-4.98Cr	-4.53Cr	-6.7Cr	-31Cr	-218.31Cr
Total Debt Repaid	-16Cr	-4.53Cr	-6.7Cr	-31Cr	-218.31Cr
Issuance of Common Stock	-	261.25Cr	3.42Cr	10.33L	81Cr
Repurchase of Common Stock	-45Cr	-4.09Cr	-9.94Cr	-2.78Cr	-4.27Cr
Common Dividends Paid	-	-	-1.54Cr	-6.98Cr	-7.2Cr
Common & Preferred Stock Dividends Paid	-	-	-1.54Cr	-6.98Cr	-7.2Cr
Other Financing Activities, Total	-1.99Cr	-9.93Cr	-	-10L	-
Cash from Financing	-63Cr	242.69Cr	98Cr	139.3Cr	55Cr
Foreign Exchange Rate Adjustments	-1.05Cr	-93.44L	-14.58L	25.48L	-41.94L
Net Change in Cash	-101.17Cr	31Cr	-134.26Cr	3.3Cr	40Cr
Supplemental Items
Cash Interest Paid	55.47L	67.57L	-	-	-
Cash Income Tax Paid (Refund)	-	-	-9.33Cr	6.02Cr	15Cr
Levered Free Cash Flow	-45Cr	-160.39Cr	-200.08Cr	-91Cr	76Cr
Unlevered Free Cash Flow	-45Cr	-159.97Cr	-198.64Cr	-86Cr	80Cr
Change In Net Working Capital	4.86Cr	32Cr	49Cr	7.94Cr	-56Cr
Net Debt Issued / Repaid	-16Cr	-4.53Cr	105.89Cr	149.05Cr	-15Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.84	-15.02	-16.73	-16.15	1.37
Return on Total Capital	2.07	-17.58	-19.63	-19.04	1.67
Return On Equity %	7.85	-23.71	-35.91	-54.15	25.37
Return on Common Equity	7.85	-23.71	-35.91	-54.15	25.37
Margin Analysis
Gross Profit Margin %	95.28	64.84	76.24	79.8	87.22
SG&A Margin	33.91	92.9	99.67	73.71	45.39
EBITDA Margin %	13.19	-143.47	-126.82	-69.53	12.06
EBITA Margin %	8.6	-159.21	-142.6	-82.84	4.38
EBIT Margin %	8.54	-159.28	-142.7	-82.98	4.3
Income From Continuing Operations Margin %	19.4	-130.09	-139.55	-85.53	21.83
Net Income Margin %	19.4	-130.09	-139.55	-85.53	21.83
Net Avail. For Common Margin %	19.4	-130.09	-139.55	-85.53	21.83
Normalized Net Income Margin	12.15	-82.16	-88.67	-54.63	1.47
Levered Free Cash Flow Margin	-31.83	-208.91	-184.76	-52.87	23.3
Unlevered Free Cash Flow Margin	-31.6	-208.36	-183.42	-50.24	24.65
Asset Turnover
Asset Turnover	0.34	0.15	0.19	0.31	0.51
Fixed Assets Turnover	1.07	0.35	0.39	0.59	1.12
Receivables Turnover (Average Receivables)	-	5.33	3.07	3.36	4.92
Inventory Turnover (Average Inventory)	0.39	0.67	0.41	0.49	0.63
Short Term Liquidity
Current Ratio	3.73	3.6	1.98	1.05	1.43
Quick Ratio	2.92	2.66	1.08	0.64	1.16
Operating Cash Flow to Current Liabilities	0.43	-1.42	-1.33	-0.51	0.02
Days Sales Outstanding (Average Receivables)	-	68.51	118.98	109.06	74.14
Days Outstanding Inventory (Average Inventory)	941.58	542.88	896.79	739.42	580.17
Average Days Payable Outstanding	151.15	135.71	138.37	208.63	195.82
Cash Conversion Cycle (Average Days)	-	475.69	877.41	639.85	458.48
Long Term Solvency
Total Debt/Equity	2.98	3.31	36.66	134.45	61.01
Total Debt / Total Capital	2.9	3.21	26.82	57.35	37.89
LT Debt/Equity	1.46	2.11	26.63	62.33	20.84
Long-Term Debt / Total Capital	1.42	2.04	19.48	26.58	12.94
Total Liabilities / Total Assets	17.14	17.29	37.82	63.88	50.21
EBIT / Interest Expense	22.85	-180.99	-66.93	-19.68	1.99
EBITDA / Interest Expense	45.26	-153.78	-56.81	-15.65	6.4
(EBITDA - Capex) / Interest Expense	-70.29	-265.6	-93.74	-19.31	3.55
Total Debt / EBITDA	0.43	-0.16	-0.96	-2.36	4.9
Net Debt / EBITDA	-6.89	1.85	-0.39	-1.68	-0.49
Total Debt / (EBITDA - Capex)	-0.27	-0.09	-0.58	-1.91	8.83
Net Debt / (EBITDA - Capex)	4.44	1.07	-0.24	-1.36	-0.89
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-46.08	40.26	58.54	89.36
Gross Profit, 1 Yr. Growth %	-	-63.31	65.11	65.94	106.95
EBITDA, 1 Yr. Growth %	-128.39	-686.4	29.32	-12.82	-132.97
EBITA, 1 Yr. Growth %	-117.22	-1.1T	30.63	-7.66	-110.05
EBIT, 1 Yr. Growth %	-117.09	-1.11T	30.3	-7.81	-109.82
Earnings From Cont. Operations, 1 Yr. Growth %	-139.59	-461.56	51.3	-2.84	-148.33
Net Income, 1 Yr. Growth %	-139.59	-461.56	51.3	-2.84	-148.33
Normalized Net Income, 1 Yr. Growth %	-139.68	-464.65	38.83	-2.32	-105.1
Diluted EPS Before Extra, 1 Yr. Growth %	-133.15	-432.45	48.94	-2.5	-147.25
Accounts Receivable, 1 Yr. Growth %	-	3.89T	49.52	42.43	19.92
Inventory, 1 Yr. Growth %	323.41	86.46	41.88	-11.08	0.32
Net Property, Plant and Equip., 1 Yr. Growth %	83.58	51.26	15.21	-4.23	4.65
Total Assets, 1 Yr. Growth %	1.01	44.77	-8.19	-0.54	31.82
Tangible Book Value, 1 Yr. Growth %	-4.35	44.55	-33.12	-44.04	87.53
Common Equity, 1 Yr. Growth %	-4.12	44.51	-30.98	-42.22	81.69
Cash From Operations, 1 Yr. Growth %	-139.94	-579.34	19.25	-25.85	-104.75
Capital Expenditures, 1 Yr. Growth %	38.69	22.84	13.25	-68.89	-24.61
Levered Free Cash Flow, 1 Yr. Growth %	-48.55	253.84	34.21	-54.57	-183.46
Unlevered Free Cash Flow, 1 Yr. Growth %	-47.85	255.52	33.62	-56.52	-192.92
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-12.79	49.12	73.26
Gross Profit, 2 Yr. CAGR %	-	-	-21.99	65.53	85.32
EBITDA, 2 Yr. CAGR %	-30.04	29.04	170.39	6.02	-46.5
EBITA, 2 Yr. CAGR %	-46.27	31.15	255.19	9.68	-69.6
EBIT, 2 Yr. CAGR %	-46.49	31.11	256.49	9.6	-69.92
Earnings From Cont. Operations, 2 Yr. CAGR %	-19.87	19.64	133.89	21.25	-31.47
Net Income, 2 Yr. CAGR %	-19.87	19.64	133.89	21.25	-31.47
Normalized Net Income, 2 Yr. CAGR %	-19.78	20.28	135.6	16.45	-77.68
Diluted EPS Before Extra, 2 Yr. CAGR %	-41.43	4.98	122.27	20.5	-32.12
Accounts Receivable, 2 Yr. CAGR %	158.14	-	672.23	45.93	30.69
Inventory, 2 Yr. CAGR %	199.51	180.98	62.65	12.32	-5.55
Net Property, Plant and Equip., 2 Yr. CAGR %	91.52	66.64	30.92	5.04	0.11
Total Assets, 2 Yr. CAGR %	145.64	20.92	15.29	-4.44	14.5
Tangible Book Value, 2 Yr. CAGR %	282.96	17.58	-2.06	-38.82	2.44
Common Equity, 2 Yr. CAGR %	285.45	17.71	-0.13	-36.85	2.47
Cash From Operations, 2 Yr. CAGR %	-3.44	38.36	138.76	-5.97	-81.23
Capital Expenditures, 2 Yr. CAGR %	207.12	30.53	17.75	-40.64	-51.57
Levered Free Cash Flow, 2 Yr. CAGR %	26.87	34.93	110.1	-21.97	-38.42
Unlevered Free Cash Flow, 2 Yr. CAGR %	33.03	36.17	110.11	-23.83	-36.44
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	401.03	-	-	6.44	61.48
Gross Profit, 3 Yr. CAGR %	728.12	-	-	0.33	78.32
EBITDA, 3 Yr. CAGR %	-5.59	42.12	27.57	85.22	-28.27
EBITA, 3 Yr. CAGR %	-20.52	42.33	29.53	126.49	-50.62
EBIT, 3 Yr. CAGR %	-20.83	42.26	29.51	127.12	-50.96
Earnings From Cont. Operations, 3 Yr. CAGR %	0.77	32.41	29.38	74.52	-10.77
Net Income, 3 Yr. CAGR %	0.77	32.41	29.38	74.52	-10.77
Normalized Net Income, 3 Yr. CAGR %	0.66	32.89	30.11	75.68	-58.95
Diluted EPS Before Extra, 3 Yr. CAGR %	-	4.48	17.87	68.88	-11.8
Accounts Receivable, 3 Yr. CAGR %	-13.7	542.94	-	339.57	36.69
Inventory, 3 Yr. CAGR %	111.4	155.75	123.75	32.99	8.17
Net Property, Plant and Equip., 3 Yr. CAGR %	63.09	77.03	46.53	17.96	4.91
Total Assets, 3 Yr. CAGR %	98.59	105.95	10.32	9.75	6.38
Tangible Book Value, 3 Yr. CAGR %	89.93	176.76	-2.83	-18.73	-11.13
Common Equity, 3 Yr. CAGR %	90.54	177.93	-1.48	-16.78	-10.18
Cash From Operations, 3 Yr. CAGR %	27.22	64.72	31.55	61.68	-65.24
Capital Expenditures, 3 Yr. CAGR %	94.4	126.29	24.35	-24.45	-35.72
Levered Free Cash Flow, 3 Yr. CAGR %	-	78.58	31.44	26.04	-20.2
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	84.61	32.05	24.22	-18.61
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	148.97	-	-
Gross Profit, 5 Yr. CAGR %	-	-	221.9	-	-
EBITDA, 5 Yr. CAGR %	-	-	43.82	25.48	-9.94
EBITA, 5 Yr. CAGR %	-	-	44.66	27.39	-27.5
EBIT, 5 Yr. CAGR %	-	-	44.53	27.38	-27.77
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	41.13	27.83	0.34
Net Income, 5 Yr. CAGR %	-	-	41.13	27.83	0.34
Normalized Net Income, 5 Yr. CAGR %	-	-	41.44	28.4	-35.72
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	10.57	-5.48
Accounts Receivable, 5 Yr. CAGR %	-	-	107.35	255.27	-
Inventory, 5 Yr. CAGR %	-	-	90.35	84.02	58.46
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	49.37	43.2	25.82
Total Assets, 5 Yr. CAGR %	-	-	59.77	51.48	11.97
Tangible Book Value, 5 Yr. CAGR %	-	-	45.73	51.09	-0.75
Common Equity, 5 Yr. CAGR %	-	-	47.15	53.65	0.08
Cash From Operations, 5 Yr. CAGR %	-	-	63.65	31.56	-39.63
Capital Expenditures, 5 Yr. CAGR %	-	-	59.07	32.4	-14.72
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	26.37	-2.97
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	27.67	-1.46